Welcome to LookChem.com Sign In|Join Free
  • or
7-Boc-1,7-diaza-spiro[4.4]nonane is a chemical compound characterized by its spirocyclic structure and a 1,7-diaza ring system. It is recognized for its role as a key building block in the synthesis of pharmaceuticals and complex organic molecules, attributed to its function as a versatile chiral auxiliary. The presence of a Boc (tert-butoxycarbonyl) protecting group on 7-Boc-1,7-diaza-spiro[4.4]nonane enhances its stability and reactivity, allowing for mild condition removal, which is advantageous in organic synthesis. Its unique stereochemical properties, stemming from the spirocyclic structure, make it an essential component in the preparation of stereoselective compounds. 7-Boc-1,7-diaza-spiro[4.4]nonane holds significant value in organic chemistry for its contribution to the synthesis of complex and biologically active molecules.

646055-63-2

Post Buying Request

646055-63-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

646055-63-2 Usage

Uses

Used in Pharmaceutical Synthesis:
7-Boc-1,7-diaza-spiro[4.4]nonane is used as a key building block for the synthesis of pharmaceuticals, leveraging its versatility as a chiral auxiliary. This attribute is crucial for the development of enantiomerically pure drugs, which are essential for ensuring the desired therapeutic effects and minimizing potential side effects.
Used in Organic Synthesis:
In the field of organic synthesis, 7-Boc-1,7-diaza-spiro[4.4]nonane is utilized as a valuable tool due to its Boc protecting group, which facilitates controlled reactions under mild conditions. This feature is particularly beneficial for the synthesis of complex organic molecules where protecting groups are necessary to prevent unwanted side reactions.
Used in Stereoselective Compound Preparation:
7-Boc-1,7-diaza-spiro[4.4]nonane is employed as a component in the preparation of stereoselective compounds, capitalizing on its unique spirocyclic structure. The stereochemistry of molecules is critical in determining their biological activity, making 7-Boc-1,7-diaza-spiro[4.4]nonane an important asset in the creation of molecules with specific biological targets and properties.
Overall, 7-Boc-1,7-diaza-spiro[4.4]nonane is a multifaceted compound with applications across various industries, primarily due to its structural features and synthetic utility in creating pharmaceuticals and complex organic molecules with high stereoselectivity.

Check Digit Verification of cas no

The CAS Registry Mumber 646055-63-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,4,6,0,5 and 5 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 646055-63:
(8*6)+(7*4)+(6*6)+(5*0)+(4*5)+(3*5)+(2*6)+(1*3)=162
162 % 10 = 2
So 646055-63-2 is a valid CAS Registry Number.
InChI:InChI=1/C12H22N2O2/c1-11(2,3)16-10(15)14-8-6-12(9-14)5-4-7-13-12/h13H,4-9H2,1-3H3

646055-63-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 1,7-Diazaspiro[4.4]nonane-7-carboxylic acid tert-butyl ester

1.2 Other means of identification

Product number -
Other names tert-butyl 1,7-diazaspiro[4.4]nonane-7-carboxylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:646055-63-2 SDS

646055-63-2Relevant academic research and scientific papers

Construction of NH-Unprotected Spiropyrrolidines and Spiroisoindolines by [4+1] Cyclizations of γ-Azidoboronic Acids with Cyclic N-Sulfonylhydrazones

Cabal, María-Paz,López, Lucía,Valdés, Carlos

supporting information, (2021/12/09)

The reactions of N-sulfonylhydrazones derived from cyclic ketones with γ-azidopropylboronic acid and 2-(azidomethyl)phenylboronic acid give rise to spirocyclic pyrrolidines and spiroisoindolines, respectively. The reactions proceed without the need of any transition-metal catalyst through a domino process that comprises the formation of a Csp3-C and a Csp3-N bond of the former hydrazonic carbon. The scope of the reaction has been explored by the preparation of over 50 examples of NH-unprotected spirocyclic derivatives. Importantly, this methodology could be applied for the preparation of alkaloid steroids from steroid N-tosylhydrazones.

Discovery of a novel bicyclic compound, DS54360155, as an orally potent analgesic without mu-opioid receptor agonist activity

Arita, Tsuyoshi,Asano, Masayoshi,Kubota, Kazufumi,Domon, Yuki,Machinaga, Nobuo,Shimada, Kousei

supporting information, (2019/11/11)

We synthesized derivatives of a natural alkaloid, conolidine, and evaluated these derivatives in the acetic acid-induced writhing test and formalin test in ddY mice after oral administration. As a result, we identified (5S)-6-methyl-1,3,4,5,6,8-hexahydro-7H-2,5-methano[1,5]diazonino[7,8-b]indol-7-one sulfate salt, 15a (DS54360155), with a unique and original bicyclic skeleton, as an analgesic more potent than conolidine. Moreover, 15a did not exhibit mu-opioid receptor agonist activity.

THE USE OF N-ARYL DIAZASPIRACYCLIC COMPOUNDS IN THE TREATMENT OF ADDICTION

-

Page/Page column 58, (2010/10/20)

Compounds, compositions and methods for treating drug addiction, nicotine addiction, and/or obesity are disclosed. The compounds are N-aryl diazaspirocyclic compounds, bridged analogs of N-heteraryl diazaspirocyclic compounds, or prodrugs or metabolites of these compounds. The aryl group can be a five- or six-membered heterocyclic ring (heteroaryl). The compounds are effective at inhibiting dopamine production and/or secretion, and accordingly are effective at inhibiting the physiological "reward" process that is associated with ingestion of nicotine and/or illicit drugs. The compounds and compositions can be administered in effective amounts to inhibit dopamine release, wihout resulting in appreciable adverse side effects (e.g., side effects such as significant increases in blood pressure and heart rate, significant negative effects upon the gastro-intestinal tract, and significant effects upon skeletal muscle).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 646055-63-2